Fujun Wang

Tianjin University — China

Immunology and Microbiology · Life Sciences

21h-index1.6kcitations86works4.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Toxin Mechanisms and Immunotoxins(13), Immunotherapy and Immune Responses(12), RNA Interference and Gene Delivery(11), Transgenic Plants and Applications(9), Oceanographic and Atmospheric Processes(7)

Publications86 total

470 Multimodal profiling reveals unique and overlapping features of rilvegostomig and PD(x) activity in NSCLC tumor explants
Regular and Young Investigator Award Abstracts·2025Open Access
Investigation of composite hardness on multi-layer using nanoscale indentation
Surface and Coatings Technology·2025· 1 cited
Expression of CLDN18.2, CDX2, SATB2, and PAX8 in Primary and Gastrointestinal-Derived Mucinous Ovarian Carcinoma
Advances in Obstetrics and Gynecology Research·2025Open Access
Engineered MAP30ER: A plant toxin-derived platform for EGFR-Targeted delivery of protein and chemotherapeutic payloads
Biochemical and Biophysical Research Communications·2025
Janus piezoelectric adhesives regulate macrophage TRPV1/Ca2+/cAMP axis to stimulate tendon-to-bone healing by multi-omics analysis
Bioactive Materials·2025· 7 citedOpen Access
GalNAc End‐Capped Poly(β‐amino ester)s with Screened Side Chains for Efficient Gene Delivery
Small Methods·2025· 7 citedOpen Access
Predicting the risk of bone metastases in patients with newly diagnosed prostate cancer – Development and validation of a nomogram model
PLoS ONE·2025Open Access
Platycodin D reduces <scp>PD</scp> ‐ <scp>L1</scp> levels by inhibiting <scp>LXR</scp> ‐β activity and combines with nintedanib to enhance the tumor‐killing effect of T cells
FEBS Letters·2024· 2 citedOpen Access
A high hydrophobic moment arginine‐rich peptide screened by a machine learning algorithm enhanced ADC antitumor activity
Journal of Peptide Science·2024· 2 citedOpen Access
A phase 1 study of the CD40 agonist MEDI5083 in combination with durvalumab in patients with advanced solid tumors
Immunotherapy·2024· 5 citedOpen Access
Saponin and Ribosome-Inactivating Protein Synergistically Trigger Lysosome-Dependent Apoptosis by Inhibiting Lysophagy: Potential to Become a New Antitumor Strategy
Molecular Pharmaceutics·2024· 2 cited
Evaluation of the feeding safety of Moringa (Moringa oleifera L.) in the Sprague Dawley rat
Scientific Reports·2024· 3 citedOpen Access
ASCT2-Targeting Antibody-Drug Conjugate MEDI7247 in Adult Patients with Relapsed/Refractory Hematological Malignancies: A First-in-Human, Phase 1 Study
Targeted Oncology·2024· 9 citedOpen Access
Curcumin inhibits prostate cancer by upregulating miR‐483‐3p and inhibiting UBE2C
Journal of Biochemical and Molecular Toxicology·2024· 18 cited
Improving combination cancer immunotherapy by manipulating dual immunomodulatory signals with enzyme-triggered, cell-penetrating peptide-mediated biomodulators
Biomaterials Science·2023· 3 cited
In Situ Vaccination with An Injectable Nucleic Acid Hydrogel for Synergistic Cancer Immunotherapy
Angewandte Chemie·2023· 3 cited
In Situ Vaccination with An Injectable Nucleic Acid Hydrogel for Synergistic Cancer Immunotherapy
Angewandte Chemie International Edition·2023· 43 cited
Cytotoxic effects of recombinant proteins enhanced by momordin Ic are dependent on cholesterol and ganglioside GM1
Toxicon·2023· 4 cited
Screening and characterisation of a novel efficient tumour cell-targeting peptide derived from insulin-like growth factor binding proteins
Journal of drug targeting·2023· 3 citedOpen Access
Improving nanochemoimmunotherapy efficacy by boosting “eat-me” signaling and downregulating “don't-eat-me” signaling with <i>Ganoderma lucidum</i> polysaccharide-based drug delivery
Journal of Materials Chemistry B·2023· 6 cited
page 1 of 5Next →

Frequent Co-authors

Jian Zhao(20), Leshuai W. Zhang(10), Xue‐Wei Cao(9), Yangyun Wang(7), Guibin Pang(6), HU Zhi-bi(5), Dunxin Hu(5), Linlin Zhang(5), Huan Yu(4), Xihui Zhang(4), Liqiang Fan(4), Madelaine M. Wohlreich(4), Xuzhong Yang(4), Shulei Zhang(3), David Pérahia(3), Michael J. Detke(3), Tianyan Jiang(3), Shijian Hu(3), Qingye Wang(3), Laurence A. Bradley(3)